A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic

L.J. Holmes, H.C. Francis, R.M. Niven (Manchester, United Kingdom)

Source: Annual Congress 2012 - Different ways to phenotype asthma
Session: Different ways to phenotype asthma
Session type: Oral Presentation
Number: 164
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L.J. Holmes, H.C. Francis, R.M. Niven (Manchester, United Kingdom). A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic. Eur Respir J 2012; 40: Suppl. 56, 164

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004


The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


The oral corticosteroid sparing effect of omalizumab in paediatric patients with severe chronic asthma
Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Year: 2010

Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Retrospective study on the use of LABA/LAMA therapy (long acting bronchodilator agent/long acting muscarinic agent) in patients with severe COPD at first diagnosis.
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019


Ciclosporin as a steroid sparing agent in children with difficult to treat asthma
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009


Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



COPD exacerbation and use of methotrexate – a nationwide study of 58,580 outpatients
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021



Combined immunosuppressive therapy including anti-TNFα in a treatment of severe paediatric sarcoidosis – a case report
Source: Eur Respir J 2006; 28: Suppl. 50, 829s
Year: 2006

A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Source: Breathe 2010; 6: 365
Year: 2010

Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where?
Source: Eur Respir J 2011; 38: 947-958
Year: 2011



Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


Cost analysis for patients with severe asthma receiving omalizumab treatment
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


Steroid sparing effect and the influence on height of Montelukast therapy in the treatment of asthmatic children: a retrospective observational study
Source: Eur Respir J 2001; 18: Suppl. 33, 290s
Year: 2001

First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007


The APEX study: A retrospective review of responses of severe allergic asthma patients to omalizumab on continuous or non-continuous oral corticosteroids in UK clinical practice
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011

Measures of adherence in patients with severe asthma prescribed systemic steroids in the U-BIOPRED cohort
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001